申请人:KARO BIO AB
公开号:US20140128435A1
公开(公告)日:2014-05-08
The invention provides a compound of formula (I) wherein G is a pyrazole ring as defined in the specification and R
4
, R
5
, R
6
and R
7
are as defined in the specification; or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity.
本发明提供了一种式(I)的化合物,其中G是在规范中定义的吡唑环,R4、R5、R6和R7如规范中所定义;或其药学上可接受的酯、酰胺、溶剂或盐,包括这样的酯或酰胺的盐,以及这样的酯、酰胺或盐的溶剂。本发明还提供了在治疗或预防与雌激素受体活性相关的疾病或紊乱的情况下使用这些化合物的方法。